What is the Share Price of Colinz Laboratories Ltd?

Colinz Laboratories Ltd share price is ₹53.50 As on 09 May, 2025|08:41

Home
>
Stocks
>
Colinz Laboratories Ltd

Colinz Laboratories Ltd Share Price

Q: What is the Market Cap of Colinz Laboratories Ltd?

The Market Cap of Colinz Laboratories Ltd is ₹24.9 As on 09 May, 2025|08:41

Q: What is PE Ratio of Colinz Laboratories Ltd?

The P/E ratio of Colinz Laboratories Ltd is 50.7 As on 09 May, 2025|08:41

Q: What is PB Ratio of Colinz Laboratories Ltd?

The PB ratio of Colinz Laboratories Ltd is 2.61 As on 09 May, 2025|08:41

₹ 0.00 0 (0%)
Updated on 01-01-1970 5:30 AM

Stock Rating

BSE

Pros 2

Cons 6

Colinz Laboratories Ltd Price Performance

Day's Low
₹0

Day's High
₹0

₹ 0

52-w low
₹0

52-w high
₹0

Day's open
₹0
Previous close
₹0
VWAP
₹0
Lower price band
₹0
Upper price band
₹0

Today's Market Action

Its last traded stock price on BSE was 53.50 up by 1.33%. The total volume of shares on NSE and BSE combined was 3,821 shares. Its total combined turnover was Rs 0.02 crores.

Colinz Laboratories Ltd Medium and Long Term Market Action

The stock price of Colinz Laboratories Ltd is down by -100% over the last one month. Don't forget to check the full stock price history in the table below.

Colinz Laboratories Ltd Fundamentals

Market Cap (Cr): 24.9
Book Value (₹):
Stock P/E:
Revenue (Cr):
Total Debt (Cr):

Face Value (₹):
Roce (%):
ROE (%):
Earnings (Cr):
Promoter’s Holdings (%):

EPS (₹):
Debt to Equity:
Dividend Yield (%):
Cash (Cr):

Colinz Laboratories Ltd Mutual fund holdings and trends

FUND NAME	Quantity	Monthly Change (Qty)

Colinz Laboratories Ltd Shareholding Pattern

Similar Stocks

Company	Price	Market Cap (Cr)	P/E

About Colinz Laboratories Ltd

Data not available.

Colinz Laboratories Ltd FAQ's

What is Share Price of Colinz Laboratories Ltd?

What is the Market Cap of Colinz Laboratories Ltd?

What is PE Ratio of Colinz Laboratories Ltd?

What is PB Ratio of Colinz Laboratories Ltd?

What is the CAGR of Colinz Laboratories Ltd?

How to Buy Colinz Laboratories Ltd Share?

Can I buy Colinz Laboratories Ltd from Samco?

How do I buy Colinz Laboratories Ltd from Samco?

Financials

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

News

Review

Pros

Great Cash Conversion of Profits
The business has a great cash conversion ratio since it is able to convert a signifant portion of operating earnings of 125.61% into operating cash flow. This implies a great working capital cycle and large cash flows for either funding growth or dividends. This shall positively impact shareholder returns.
Zero Debt
The company has almost nil to negligible debt to equity ratio of 0.09. Considering the fact that the business is debt free, equity shareholders shall carry lower risk of holding the stock.

Cons

Low Sustainable RoE
The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
Low Return on Capital Employed
The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
Highly Cyclical Industry
The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
Low Pricing Power & High Competition
The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
Poor Capital Allocation
The company has disproportionately high amount of assets locked up in working capital, cash and cash equivalents, loans and advances, etc to the extent of 78.56 % of total assets. This reflects poorly on the capital allocation strategy of the management which negatively impacts shareholder returns.
Poor Corporate Governance
The general corporate governance standards of the company are poor which can negatively impact shareholder value and returns.

Valuation Analysis

Margin of safety
(09/05/2025)

107

Margin of Safety Index: Very High

100.00%

100.00% People are bullish about Colinz Laboratories Ltd

0.00%

0.00 % People are bearish about Colinz Laboratories Ltd

What is your opinion about this Stock?

Historical Data

Date	Open	High	Low	Close	Volume	Daily Change %